Quantamental Technologies LLC Immuno Gen, Inc. Transaction History

Quantamental Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $117,183 - $626,542	31,249 New	31,249 $589,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $20,160 - $29,115	-4,500 Reduced 25.77%	12,959 $62,000
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $54,995 - $100,563	17,459 New	17,459 $79,000
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $157,730 - $276,954	-37,026 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $175,873 - $277,695	37,026 New	37,026 $275,000
Q2 2019 Aug 12, 2019	SELL	$1.8 - $3.3 $84 - $155	-47 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$2.41 - $5.91 $113 - $277	47 New	47 $0

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.